Safety and tolerability of anifrolumab, a monoclonal antibody targeting type I interferon receptor, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study
Yoshiya Tanaka, Tsutomu Takeuchi, Masato Okada, Tomonori Ishii, Hiroshi Nakajima, Shinichi Kawai, Takao Nagashima, Nobuya Hayashi, Liangwei Wang, Raj Tummala
研究成果: Article › 査読
10
被引用数
(Scopus)